Projects funded by the NCN

Integrated multi-omics approach to accelerate anticancer drug discovery by targeting metabolic reprogramming in human co...

Call: OPUS 26 , Panel: NZ7

Principal investigator: dr hab. Danuta Dudzik

Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

Targeting of metabolic and transcriptomic cross-talk between leukemic cells and macrophages as a therapeutic strategy in...

Call: OPUS 22 , Panel: NZ5

Principal investigator: dr Baran Natalia

Instytut Hematologii i Transfuzjologii

Inhibiting the Mitochondrial Intermembrane Space Assembly pathway as a newapproach to prevent metabolic reprogramming of...

Call: OPUS 22 , Panel: NZ5

Principal investigator: dr hab. Carlo Vascotto

Instytut Hematologii i Transfuzjologii

Metabolic reprogramming in age-dependent endothelial dysfunction and vascular stiffness; novel mechanism of 'inflamm-age...

Call: MAESTRO 13 , Panel: NZ4

Principal investigator: prof. Stefan Chłopicki

Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

Modulation of ATP production using glycolysis inhibitors in cancer cells monitored by novel biosensing systems based on ...

Call: PRELUDIUM 19 , Panel: ST4

Principal investigator: Katarzyna Ratajczak

Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii